Emery-Dreifuss Muscular Dystrophy Type 2

Disease Overview

Emery-Dreifuss Muscular Dystrophy Type 2 (EDMD2) is a rare genetic disorder characterized by progressive muscle weakness, joint contractures, and cardiac complications. The condition typically manifests in childhood or early adulthood, affecting muscle and heart function through mutations in the LMNA gene.

Disease Category

Neuromuscular Disorders Subtype: Muscular Dystrophy Inheritance Pattern: Autosomal Dominant

Synonyms

AD-EDMD
Autosomal Dominant Emery-Dreifuss Muscular Dystrophy
LMNA-Related Muscular Dystrophy

Signs & Symptoms

Primary symptoms include: - Progressive muscle weakness (shoulders, upper arms, lower legs) - Early-onset joint contractures (elbows, ankles, neck) - Cardiac conduction defects - Muscle atrophy - Reduced mobility - Potential respiratory complications - Fatigue - Potential cardiac arrhythmias

Causes

Genetic mutations in the LMNA gene
Affects nuclear envelope protein production
Autosomal dominant inheritance pattern
Single mutated gene copy can cause disorder
Disrupts nuclear membrane structural integrity

Affected Populations

Prevalence: Rare (estimated 1-5 per 100,000 individuals)
Age of Onset: Childhood to early adulthood (typically 5-15 years)
Gender Distribution: Equal affect across males and females
Worldwide occurrence without significant ethnic predisposition

Disorders with Similar Symptoms

Duchenne Muscular Dystrophy
Becker Muscular Dystrophy
Limb-Girdle Muscular Dystrophy
Congenital Muscular Dystrophy
X-linked Emery-Dreifuss Muscular Dystrophy

Diagnosis

Diagnostic Approach: - Comprehensive clinical evaluation - Detailed family medical history - Genetic testing for LMNA mutations - Electromyography (EMG) - Muscle biopsy - Cardiac screening (ECG, echocardiogram) - Genetic counseling

Standard Therapies

Management Strategies: - Multidisciplinary care approach - Physical therapy - Orthopedic interventions - Cardiac monitoring - Assistive devices - Potential cardiac medications - Genetic counseling - Symptomatic treatment

Clinical Trials and Studies

Ongoing research at major medical centers
Potential gene therapy investigations
Clinical trial information available at ClinicalTrials.gov
Emerging therapeutic approaches under investigation

References

Genetics Home Reference
National Institutes of Health
Muscular Dystrophy Association publications
Peer-reviewed genetic research journals

Programs & Resources

Muscular Dystrophy Association (MDA)
National Organization for Rare Disorders (NORD)
Genetic and Rare Diseases Information Center
Patient support groups
Online genetic counseling resources

Complete Report

Comprehensive medical documentation detailing EDMD2's genetic, clinical, and management aspects. Recommended consultation with specialized medical professionals for personalized guidance.

Note: Medical information provided is for educational purposes. Always consult healthcare professionals for specific medical advice and current treatment protocols.